You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Covid-19: Cambodia approves emergency use of China's Sinovac vaccine

Cambodia officially approved the emergency use of China's Sinovac Covid-19 vaccine, the country's Health Minister Mam Bunheng said on Friday.

Coronavirus | Coronavirus Vaccine

IANS  |  Phnom Penh 

Coronavirus, vaccine, covid, drugs, clinical trials
Representative Image

Cambodia officially approved the emergency use of China's Sinovac Covid-19 vaccine, the country's Health Minister Mam Bunheng said on Friday.

"Taking into account of the pandemic of Covid-19, with a view to protecting life and health of Cambodian people, the Ministry of Health of the Kingdom of Cambodia has decided to grant Sinovac Covid-19 vaccine for the Emergency Use Authorization (EUA) in Cambodia, he said in a statement.

Sinovac Covid-19 vaccine has been used safely in China and other countries, the minister was quoted as saying by the Xinhua news agency.

The EUA of the vaccine will take into effect immediately, he said.

On February 4, Cambodia also approved the emergency use of China's Sinopharm Covid-19 vaccine, saying that it is used safely in China and other countries.

The Southeast Asian nation kicked off an anti-Covid-19 inoculation drive on February 10, days after receiving the first batch of Sinopharm vaccine from China.

Cambodia has seen remarkable success in containing the spread of Covid-19. The kingdom has so far registered a total of 479 confirmed Covid-19 cases, with zero deaths and 463 recoveries, according to the Ministry of Health



(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, February 13 2021. 07:42 IST